Is residual nodal disease at axillary dissection associated with tumor subtype in patients with low volume sentinel node metastasis after neoadjuvant chemotherapy?

TA Moo, KR Pawloski, J Flynn, M Edelweiss… - Annals of surgical …, 2021 - Springer
Background In patients with a positive sentinel lymph node (SLN) after neoadjuvant
chemotherapy (NAC), the likelihood of residual nodal disease at axillary dissection (ALND) …

[HTML][HTML] Predictors of non-sentinel lymph node metastasis in clinical early stage (cT1-2N0) breast cancer patients with 1-2 metastatic sentinel lymph nodes

A Lale, M Yur, H Özgül, EG Alkurt, N Yıldırım… - Asian Journal of …, 2020 - Elsevier
Objective The purpose of this study was to determine the risk factors that caused non-
sentinel lymph nodes (nonSLNs) metastasis by considering the clinicopathological …

[HTML][HTML] Prediction of nonsentinel lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes

B Öz, A Akcan, S Doğan, Ü Abdulrezzak, D Aslan… - Asian journal of …, 2018 - Elsevier
Objective The aim of the present study was to investigate the association between non
sentinel lymph node metastasis (NSLNM) and clinicopathological factors, particularly in the …

Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node …

S Majid, L Rydén, J Manjer - BMC cancer, 2019 - Springer
Background Sentinel node biopsy (SNB) is the standard procedure for axillary staging in
patients with clinically lymph node negative invasive breast cancer. Completion axillary …

Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the …

CD van Steenbeek, MC van Maaren, S Siesling… - BMC medical research …, 2019 - Springer
Background Clinical prediction models are not routinely validated. To facilitate validation
procedures, the online Evidencio platform (https://www. evidencio. com) has developed a …

Risk factors and a predictive nomogram for non-sentinel lymph node metastases in Chinese breast cancer patients with one or two sentinel lymph node …

XY Wang, JT Wang, T Guo, XY Kong, L Chen, J Zhai… - Current …, 2019 - mdpi.com
Background: Two ongoing prospective randomized trials are evaluating whether omitting
axillary lymph node dissection (alnd) in patients with breast cancer (bca) and sentinel lymph …

Association between postoperative pathological results and non-sentinel nodal metastasis in breast cancer patients with sentinel lymph node-positive breast cancer

L Dong, S Wei, Z Huang, F Liu, Y Xie, J Wei… - World Journal of …, 2024 - Springer
Objective For patients with 1–2 positive sentinel lymph nodes (SLN) identified by biopsy, the
necessity of axillary lymph node dissection (ALND) remains a matter of debate. The primary …

[HTML][HTML] Impact of size of the tumour, persistence of estrogen receptors, progesterone receptors, HER2Neu receptors and Ki67 values on positivity of axillary lymph …

B Kondov, R Isijanovska, Z Milenkovikj… - … Journal of Medical …, 2017 - ncbi.nlm.nih.gov
AIM: The study aimed to identify factors that influence the positivity of axillary lymph nodes in
patients with early breast cancer and clinically negative axillary lymph nodes, who were …

Prognostic factors on the positivity for metastases of the axillary lymph nodes from primary breast cancer

B Kondov, G Kondov, Z Spirovski, Z Milenkovikj… - prilozi, 2017 - sciendo.com
Aim: The aim of the study was to identify the impact of T stage, the presence of estrogen,
progesterone, HER2neu receptors and the values of the Ki67 on the positivity for metastases …

[HTML][HTML] Axillary lymph node dissection on the run?

N Maeseele, J Faes, T Van de Putte… - Facts, views & vision …, 2017 - ncbi.nlm.nih.gov
The standard approach of performing a completion axillary lymph node dissection (cALND)
after a positive sentinel node for breast cancer patients is no longer generally accepted. This …